Page 19 - PRECONGRESS COURSE 06

ESHRE PCC 6: Ovarian Stimulation for IVF: Individualization and beyond:
The stimulation drug FSH: What do we need to know?
Disclosure
Joop S.E. Laven, M.D., Ph.D., Senior Consultant OBGYN, Professor Reproductive Medicine
Div. Reproductive Medicine, Dept. Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam,
The Netherlands
 Past President of the Dutch Society for Reproductive Medicine (DSRM)
 Past Chairman of the Task force Reproductive Endocrinology of the Royal Dutch College of Obstetrics
and Gynaecology (RDCOG)
 Past chairman of the Guideline development group: Initial work-up for infertile couples (RDCOG)
 Chairman of the Guideline Development Group Diagnosis and Screening of the International Guideline
on PCOS
 Received unrestricted research grants from Ferring®, Merck Serono®, MSD®, Organon®, Serono® and Shering-Plough®
 Received grants from the Erasmus Trust Fund and from Erasmus MC Holding
 Received grants from the Dutch Genomics Initiative and from the Dutch Heart Association
 Past Member of the Editorial Board of Human Reproduction
 Member of the Editorial Board of Human Reproduction Update and Journal of the Endocrine Society
Page 15 of 258
PRECONGRESS COURSE 06 I GENEVA, SWITZERLAND – 2 JULY 2017 19